ArticleFrontiers in cardiovascular medicine2026

Correction: A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocol.

Jingjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.